THOMAS C VANHOOSE

Allopathic & Osteopathic Physicians|Internal Medicine VANCOUVER, WA NPI 1891154530

General Payments — all program years on this page

$968.51

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 54
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $229.50 across 13 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $229.5013

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Novo Nordisk AS $42.122
Acerta Pharma LLC $35.112
GlaxoSmithKline, LLC. $33.882
Amgen Inc. $30.562
Lilly USA, LLC $29.672
PFIZER INC. $21.721
ABBVIE INC. $21.411
Bayer HealthCare Pharmaceuticals Inc. $15.031

By program year

Program yearAmountRecords
2021 $324.7419
2022 $212.9513
2023 $201.329
2024 $229.5013

Records — PY2024 (13)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086262006 Bayer Healthcare Pharmaceuticals Inc. $15.03 11/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096666974 Novo Nordisk Inc $23.59 11/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097707802 Novo Nordisk Inc $18.53 10/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104234765 AstraZeneca Pharmaceuticals LP $19.99 02/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105631313 AstraZeneca Pharmaceuticals LP $15.12 03/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106270220 ABBVIE INC. $21.41 09/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116145450 GlaxoSmithKline, LLC. $19.11 11/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116191638 Amgen Inc. $16.02 05/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116191643 Amgen Inc. $14.54 09/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116523658 GlaxoSmithKline, LLC. $14.77 02/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131755304 PFIZER INC. $21.72 07/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135437891 Lilly USA, LLC $14.68 02/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135437893 Lilly USA, LLC $14.99 05/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.